Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC...

50
Systematic Review Module 6: Systematic Review Module 6: Data Abstraction Data Abstraction Joseph Lau, MD Joseph Lau, MD Thomas Trikalinos, MD, PhD Thomas Trikalinos, MD, PhD Tufts EPC Tufts EPC Melissa McPheeters, PhD, MPH Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Jeff Seroogy, BS Vanderbilt University EPC Vanderbilt University EPC

Transcript of Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC...

Page 1: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Systematic Review Module 6: Systematic Review Module 6: Data AbstractionData Abstraction

Joseph Lau, MDJoseph Lau, MDThomas Trikalinos, MD, PhDThomas Trikalinos, MD, PhD

Tufts EPCTufts EPC

Melissa McPheeters, PhD, MPH Melissa McPheeters, PhD, MPH Jeff Seroogy, BSJeff Seroogy, BS

Vanderbilt University EPCVanderbilt University EPC

Page 2: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

CER Process OverviewCER Process Overview

2

Prepare topic:

· Refine key questions

· Develop analytic frameworks

Search for and select

studies:

· Identify eligibility criteria

· Search for relevant studies

· Select evidence for inclusion

Abstract data:

· Extract evidence from studies

· Construct evidence tables

Analyze and synthesize data:

· Assess quality of studies

· Assess applicability of studies

· Apply qualitative methods

· Apply quantitative methods (meta-analyses)

· Rate the strength of a body of evidence

Present findings

Page 3: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Learning ObjectivesLearning Objectives

What is data abstraction? Why do it? What kind of data to collect? How much data to collect? How to collect data accurately and efficiently? How many extractors? With what background? How do abstraction forms look like? What are some challenges in data abstraction? Is it feasible to query original authors?

3

Page 4: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Aims of Data AbstractionAims of Data Abstraction

Summarize studies to facilitate synthesis Identify numerical data for meta-

analyses Obtain information to assess the quality

of studies more objectively Identify future research needs

4

Page 5: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

On Data Abstraction (I)On Data Abstraction (I)

Abstracted data should– accurately reflect information reported in the

publication

– remain in a form close to the original reporting (so that disputes can be easily resolved)

– provide sufficient information to understand the studies and to perform analyses

Abstract what is needed (avoid over doing it); data abstraction is labor intensive and can costly and error prone

Different question may have different data needs

5

Page 6: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

On Data Abstraction (II)On Data Abstraction (II)

Involves more than copying words and numbers from the publication to a form

Clinical domain, methodological, and statistical knowledge is needed to ensure the right information is captured

Interpretation of published data is often needed Quality assessment of articles belongs in this step Appreciate the fact that what is reported is

sometimes not necessarily what was carried out

6

Page 7: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

What Data to Collect?What Data to Collect?

Guided by key questions and eligibility criteria Anticipate what data the summary tables should

include, what data will be needed to answer questions, and conduct meta-analyses

Data extraction follows the PICO format and include study design– Population

– Intervention or exposure

– Comparators (when applicable)

– Outcomes and numbers

– Study design

7

Page 8: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Data Elements: P, I, CData Elements: P, I, C

Population-generic elements may include patient characteristics such as age, gender distribution, and disease stage. May need more specific items according to topic

Intervention or exposure and comparator items depend on the abstracted study– RCT, observational study, diagnostic test

study, prognostic factor study, family-based or population-based genetic studies, etc.

8

Page 9: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Data Elements: OData Elements: O

Outcomes should be determined a priori with Technical Expert Panel

Criteria often are not clear as to which outcomes to include and which to discard– Mean change in ejection fraction or proportion

with increase in ejection fraction by > 5%

May be useful to record different outcome definitions and consult content experts before making a decision

9

Page 10: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Data Elements: OData Elements: O

Apart from data on outcome definitions, you need quantitative data for meta-analysis– Dichotomous (deaths, strokes, MI, etc.)– Continuous variables (mmHg, pain score, etc.)– Survival curves– Sensitivity, specificity, Receiver Operating

Characteristic (ROC)– Correlations– Slopes

10

Page 11: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Data Elements: Study DesignData Elements: Study Design

Varies by type of study Some information to consider collecting when

recording study characteristics for RCTs– Number of centers (multi-center studies)

– Method of randomization (adequacy of allocation concealment)

– Blinding

– Funding source

– Intention to treat (ITT), lack of standard definition

11

Page 12: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Clarifying EPC LingoClarifying EPC Lingo

In the EPC program, we often refer to the following types of tables:– Evidence tables are prettified data

extraction forms. Typically, each study is abstracted to a set of evidence tables.

– Summary tables synthesize evidence tables to summarize studies. They contain context-relevant pieces of the information included in the study-specific evidence tables.

12

Page 13: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Developing Data Abstraction Developing Data Abstraction Forms (Evidence Tables)Forms (Evidence Tables)

No single generic form will fit all needs While there are common generic elements, in

general, form needs to be modified for each topic or study design

Organization of information in PICO format highly desirable

Well-structured form vs. flexible form Anticipate the need to capture “unanticipated”

data Iterative process, needs testing on multiple

studies by several individuals

13

Page 14: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Common Problems when Creating Common Problems when Creating Extraction Forms (Evidence Tables)Extraction Forms (Evidence Tables)

Forms have to be constructed before any serious data extraction is underway– Original fields may turn out to be inefficient

or unusable

In practice, reviewers have to – Be as thorough as possible in the initial

set-up

– Reconfigure the tables as needed

– Dual review process helps fill in gaps

14

Page 15: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

ExampleExample

First draftFirst draft Second draft Second draft

15

Page 16: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

ExampleExample

Final draftFinal draft

16

Page 17: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Common Problems when Creating Common Problems when Creating Extraction Forms (Evidence Tables)Extraction Forms (Evidence Tables)

Lack of uniformity among outside reviewers– No matter how clear and detailed the

instructions, data will not be entered identically from one reviewer to the next

Solutions– Evidence Table Guidance document—

instructions on how to input data

– Limit the amount of core members handling the evidence tables to avoid discrepancies in presentation

17

Page 18: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

ExampleExample

From the Vanderbilt EPC Evidence Table Guidance document– The “Country, Setting” field: provides a list

of possible settings that could be encountered in the literature Academic medical center(s), community,

database, tertiary care hospital(s), specialty care treatment center(s), substance abuse center(s), level I trauma center(s), etc.

– The “Study design” field: cross-sectional, longitudinal, case-control, RCT, etc.

18

Page 19: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

ExampleExample

Reviewer AReviewer A Reviewer B Reviewer B

19

Page 20: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Samples of Final Data Extraction Samples of Final Data Extraction Forms (Evidence Tables)Forms (Evidence Tables)

For evidence reports or technology assessments with many key questions, data extraction forms may become very long (several pages)

The next few slides are examples of data extraction forms: do not study them, just fly through them

When you design your own extraction forms, improvise: there are many possible functional versions

20

[Technology Assessment on home monitoring of obstructive sleep apnea syndrome AHRQ, 2007, Tufts EPC]

Page 21: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Patient and Study Patient and Study CharacteristicsCharacteristics

Technology Assessment Home diagnosis of sleep apnea-hypopnea syndrome www.ahrq.gov

21

Page 22: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Characteristics of Index Test Characteristics of Index Test and Reference Standardand Reference Standard

Technology Assessment Home diagnosis of sleep apnea-hypopnea syndrome www.ahrq.gov

22

Page 23: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Results (Concordance/Accuracy)Results (Concordance/Accuracy)

Technology Assessment Home diagnosis of sleep apnea-hypopnea syndrome

23

Page 24: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Results (Nonquantitative)Results (Nonquantitative)

24

Technology Assessment Home diagnosis of sleep apnea-hypopnea syndrome www.ahrq.gov

Page 25: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Considerations in Managing Considerations in Managing Data AbstractionData Abstraction

How to maximize scientific accuracy under budgetary and logistical constraints?

How many people should extract data? Should data extraction be performed

“blinded” to the author, affiliations, journal, results?

How to resolve discrepancies?

25

Page 26: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Typical EPC Evidence Typical EPC Evidence ReportsReports

Systematic review of a topic 5 key questions (e.g., prevalence, diagnosis,

management, future research) Analytic framework, evidence tables, summary

tables, meta-analyses, decision models 12 months from start to completion of final report Screen 5,000 to >10,000 abstracts Examine several hundred full-text articles Synthesize 100 to 300 articles 100 to >200 pages in length

26

Page 27: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Estimating Time to Conduct a Estimating Time to Conduct a Meta-analysisMeta-analysis from Number of Citations Retrievedfrom Number of Citations Retrieved

Metaworks Inc. project summary (EPC I)– 37 meta-analysis projects

– Mean total number of hours: 1,139 hours

– Median: 1,110 hours (216 to 2,518 hours)

– Pre-analysis activities (literature search, retrieval, screening, data extraction): 588 hours (standard deviation 337 hours)

– Statistical analysis: 144 hours (106)

– Report and manuscript: 206 hours (125)

– Administrative: 201 hours (193)

27

Allen IE, Olkin I. JAMA 1999;282:634-35.Allen IE, Olkin I. JAMA 1999;282:634-35.

Page 28: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Fixed and Variable Costs Associated Fixed and Variable Costs Associated with Systematic Reviewswith Systematic Reviews

JAMA 1999;282:634-35.

28

Page 29: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Tools Available for Data Abstraction Tools Available for Data Abstraction and Collection (Pros and Cons)and Collection (Pros and Cons)

Word processing software (MS Word) Spreadsheet (MS Excel) Database software (e.g., MS Access,

Epi-Info) Dedicated off-the-shelf commercial

software (e.g., TrialStat) Homegrown software

29

Page 30: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Who Should Abstract Data Who Should Abstract Data and How Many People?and How Many People?

Domain experts vs. methodologists Single or double independent

abstraction followed by reconciliation vs. single and independent verification

Blinded (to authors, journal, results) data abstraction?

Berlin J. Does blinding of readers affect the results of meta-analysis?Berlin J. Does blinding of readers affect the results of meta-analysis? Lancet Lancet 1997;350:185-186.1997;350:185-186.

30

Page 31: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Challenges in Data Extraction Challenges in Data Extraction

Problems in data reporting Inconsistencies in published papers Data reported in graphs

31

Page 32: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Examples of Data Reporting Examples of Data Reporting Problems in the LiteratureProblems in the Literature

“Data for the 40 patients who were given all 4 doses of medications were considered evaluable for efficacy and safety. The overall study population consisted of 10 (44%) men and 24 (56%) women, with a racial composition of 38 (88%) whites and 5 (12%) blacks.”

[Verbatim]]

32

Page 33: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Examples of Data Reporting Examples of Data Reporting ProblemsProblems

33

Page 34: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Examples of Data Reporting Examples of Data Reporting ProblemsProblems

34

Page 35: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Inconsistencies in Published Inconsistencies in Published PapersPapers

Let’s extract the number of deaths in two arms, at 5 years of follow-up.

35

Page 36: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Results Text Results Text

36

Overall Mortality Overall Mortality

[…] […] 2424 deaths occurred in deaths occurred in the the PCIPCI group, […] and group, […] and 2525 in the in the MTMT group […] group […]

[Verbatim][Verbatim]

PCIPCI

(205)(205)

MEDMED

(203)(203)

DeadDead 2424 2525

Page 37: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Overall Mortality (Figure 2 in Overall Mortality (Figure 2 in Manuscript)Manuscript)

PCIPCI

(205)(205)

MTMT

(203)(203)

DeadDead 2424 2525

28 35

[The paper clearly states that there is no censoring]

37

Page 38: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Clinical Events (Table 2 in Clinical Events (Table 2 in Manuscript) Manuscript)

38

PCIPCI

(205)(205)

MT

(203)

DeadDead 2424

2828

3232

2525

3535

3333

Page 39: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Digitizing Data Reported in Digitizing Data Reported in GraphsGraphs

39

Page 40: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Data Are Often Presented in Data Are Often Presented in Graphical FormGraphical Form

Ayappa I et al. Sleep. 2004 Sep 15;27(6):1171-9

We want to We want to dichotomize dichotomize measurements measurements for a 2 x 2 table:for a 2 x 2 table:

Cutoff should be 15 Cutoff should be 15 (events per hour) (events per hour) in each axis.in each axis.

This information is This information is not reported in not reported in the paper, but the paper, but can be extracted can be extracted from the graph: from the graph: count the dots!count the dots!

40

Page 41: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Using Digitizing SoftwareUsing Digitizing Software

Engauge Digitizer,an open-source software:

Each data point is marked with a red “X,” and the coordinates are given in a spreadsheet.

digitizer.sourceforge.net

41

Page 42: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Reconstructing the Plot to Count Reconstructing the Plot to Count Classification at Specific CutoffsClassification at Specific Cutoffs

42

Page 43: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Reconstructing a Bland-Reconstructing a Bland-Altman PlotAltman Plot

43

Page 44: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Additional Common IssuesAdditional Common Issues

Missing information in published papers Variable quality of studies Publications with at least partially

overlapping patient subgroups Variable quality of conduct and quality Potentially fraudulent data

44

Page 45: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Considerations When Contacting Considerations When Contacting Authors for More InformationAuthors for More Information

How important is the information likely to be?

How reliable are additional data? How likely are you to be successful? How much effort is required? Where else should you look for more

data?– FDA website– ClinicalTrials.gov - Results Database

45

Page 46: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Types of Missing DataTypes of Missing Data

Detailed PICOTS information (e.g., population demographics, background diet, comorbidities, concurrent medications, precise definitions of outcomes)

Information to assess methodological quality (e.g., randomization methods, blinding)

Necessary statistics for meta-analysis (e.g., standard error, sample size, confidential interval, exact p-value)

46

Page 47: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

A Nonexhaustive List of Common A Nonexhaustive List of Common Data Abstraction ProblemsData Abstraction Problems

Non-uniform outcomes (e.g., different pain measurements in different studies)

Incomplete data (frequent problem: no standard error or confidence interval)

Discrepant data (different parts of the same report gave different numbers)

Confusing data (cannot figure out what the authors reported)

Nonnumeric format (reported as graphs) Missing data (only the conclusion is reported) Multiple (overlapping) publications of the same study

with or without discrepant data

47

Page 48: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Why Do Such Problems Why Do Such Problems Exist?Exist?

It is an eye-opening experience to attempt to extract information from a paper that you have read carefully and thoroughly understood only to be confronted with ambiguities, obscurities, and gaps in the data that only an attempt to quantify the results reveals.

Gurevitch J, Hedges LV. Chapter 17. Meta-analysis: Combining the Gurevitch J, Hedges LV. Chapter 17. Meta-analysis: Combining the results of independent experiments. (pg 383). In: Design and analysis of results of independent experiments. (pg 383). In: Design and analysis of ecological experiments. Samuel M. Scheiner, Jessica Gurevich, eds. ecological experiments. Samuel M. Scheiner, Jessica Gurevich, eds. Chapman & Hall, New York, 1993.Chapman & Hall, New York, 1993.

48

Page 49: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Why Do Such Problems Why Do Such Problems Exist?Exist?

Because so few research reports give effect size, standard normal deviates, or exact p-values, the quantitative reviewer must calculate almost all indices of study outcomes . . . Little of this calculation is automatic because results are presented in a bewildering variety of forms and are often obscure.

Green BF, Hall JA. Quantitative methods for literature reviews. Annual Green BF, Hall JA. Quantitative methods for literature reviews. Annual Review of psychology 1984;35:37-53.Review of psychology 1984;35:37-53.

49

Page 50: Systematic Review Module 6: Data Abstraction Joseph Lau, MD Thomas Trikalinos, MD, PhD Tufts EPC Melissa McPheeters, PhD, MPH Jeff Seroogy, BS Vanderbilt.

Closing RemarksClosing Remarks

Laborious, tedious, (could take an hour or more per article); nothing is automatic

To err is human Interpretation and subjectivity are

unavoidable Data often not reported in a uniform

manner (e.g., quality, location in paper, metrics, outcomes, numerical value vs. graphs)

50